Dr Carmela Ricciardelli

Senior Research Fellow (C)

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

My postdoctoral studies were undertaken in the Department of Surgery, Flinders Medical Centre, South Australia and Dame Roma Mitchell Cancer Research Laboratories, Hanson Institute, South Australia (1996-2003) and I joined the Discipline of Obstetrics and Gynecology, University of Adelaide in 2005. I have received highly competitive fellowships in the Faculty of Health Sciences, University of Adelaide and Cancer Council SA (2004-2014) which have enabled me to build a Reproductive Cancer research group in the Discipline of Obstetrics and Gynaecology, University of Adelaide. I was recently awarded the inaugural Lin Huddleston Ovarian Cancer Research Fellowship,Cancer Council SA (2016-2020).

My Research
Career
Publications
Grants and Funding
Teaching
Supervision
Contact

Dr Ricciardelli a cancer cell biologist; joined the Discipline of Obstetrics and Gynaecology in April 2005. She was awarded her Ph D in 1996 (Flinders University) and has undertaken postdoctoral studies in the Department of Surgery, Flinders Medical Centre, South Australia (1996-2001) and Dame Roma Mitchell Cancer Research Laboratories, Hanson Institute, South Australia (2002-2005). In 2005 Dr Ricciardelli was awarded a Tall Poppy Award for outstanding achievement in the field of biomedical and clinical science. In 2007 she was the recipient of the highly competitive Hilda Farmer Fellowship in Faculty of Health Sciences, University of Adelaide which has enabled her to build a Reproductive cancer research group in the Discipline of O&G, University of Adelaide. In 2012 Dr Ricciardelli was awarded a senior fellowship funded by SAHMRI and Cancer Council SA. In 2015 Dr Ricciardelli was awarded the Lin Huddleston Ovarian Cancer Fellowship funded by Cancer Council SA & Adelaide Medical School, University of Adelaide

Dr Ricciardelli's research program has focused on hormone-regulated proteins and prognostic markers in breast and prostate cancer. Using a novel approach in her postdoctoral studies by examining the non-cancer stromal cells which surround the cancer cells, Dr Ricciardelli was the first researcher to identify that the expression of the extracellular matrix protein, versican correlated with cancer spread in prostate and breast cancer. This was an exciting and unique discovery that has lead to versican expression being examined in many different cancer types. Versican is a molecule known to regulate cellular movement at critical periods in the developing embryo, and control the movement of normal smooth muscle cells, nerves and fibroblasts. Dr Ricciardelli's recent studies suggest that cancer cells can utilize stromally derived versican to aid their movement.

Dr Ricciardelli current research focuses on further understanding the cross-talk between breast and ovarian cancer cells and the tumour microevironment.The Reproductive Cancer Group seeks to understand the mechanisms involved in ovarian cancer spread, resistance to chemotherapy and the identification of novel biomarkers for early detection.

Project 1
Title: Extracellular vesicles: Identification of novel biomarkers and therapeutic targets for serous ovarian cancer

Description: Extracellular versicles (EVs) are nano-sized membrane-bound particles produced by virtually all cells in the body. They are found in all bodily fluids including the blood of ovarian cancer patients. EVs provide a major route of communication between different cell types throughout the body as they contain DNA, protein, RNA and lipid cargo characteristic of their cells of origin, which can be transferred to distant cells and affect their function. Extracellualr vesicles (EVs) are found in increasing numbers in the blood circulation under certain conditions, e.g. during normal pregnancy, and in cancer. The RNA and protein content of EVs have been characterised in studies of various commercially available cancer cell lines, including ovarian cancer cells; but few studies to date have focussed on ovarian cancer patient blood samples. This study will examine the proteomic profile in EVs isolated from patients with diagnosed late stage serous ovarian cancer, compared to benign serous cystadenomas and healthy controls. Candidate proteins that are differentially expressed will be validated and further characterized in ovarian cancer patient cohorts and using functional assays (adhesion, migration and invasion assays).

Location: Adelaide Health and Medical Science Building , North Terrace

Research project start: Semester 1 & 2

Project 2
Title: Novel mechanisms of acquired chemotherapy resistance in serous ovarian cancer

Ovarian cancer is the most lethal gynaecological cancer and ranks as the fifth most common cause of cancer-related death in women in the Western world. Each year over 1,500 women are diagnosed with ovarian cancer and approximately 1,000 women die from this disease in Australia. The standard treatment for advanced ovarian cancer is surgery followed by chemotherapy. Although patients initially respond to this treatment, most patients relapse and develop resistance to chemotherapy and eventually die from the disease. Development of chemoresistance is the main factor contributing to ovarian cancer death. The molecular pathways associated with acquired carboplatin resistant in serous ovarian cancer cells are poorly understood. Links have been demonstrated between chemoresistance and the activation of cancer stem cells, epithelial mesenchymal transition (EMT) and non-coding RNA pathways. A greater understanding of these pathways and mechanisms in a 3D model systems will lead to the identification of novel treatment strategies that can overcome chemotherapy resistance. This study will identify molecules associated with chemotherapy resistance that may be used to predict patient prognosis or as novel therapeutic targets.

Location: Adelaide Health and Medical Science Building , North Terrace

Research project start: Semester 1 & 2

Appointments

Date	Position	Institution name
2016 - 2020	Lin Huddleston Ovarian Cancer Fellow	University of Adelaide
2015 - 2015	Lloyd Cox Senior Research Fellow	University of Adelaide
2012 - 2014	Cancer Council South Australia Senior Fellow	University of Adelaide

Awards and Achievements

Date	Type	Title	Institution Name	Country	Amount
2010	Award	Most Outstanding Contribution to the Discipline of Obstetrics and Gynaecology	-	-	-
2008	Award	Travel award Cancer Council SA	-	-	-
2006	Fellowship	Hilda Farmer University Fellowship, University of Adelaide	-	-	-
2005	Award	Tall Poppy award, Australian Institute of Political Science for outstanding achievement in the field of biomedical and clinical science	-	-	-
2003	Fellowship	Cancer Research Fellowship, Cancer Council South Australia	-	-	-
1992	Scholarship	Flinders University Scholarship (Postgraduate)	-	-	-
1986	Award	Martin Hansen Award for Dux of Class in B App Science in Medical Laboratory Science (Australian Institute of Medical Laboratory Science)	-	-	-

Language Competencies

Language Competency
Italian Can read, write, speak and understand spoken
Education

Date Institution name Country Title
1996 Flinders University Australia Ph D
1986 University of South Australia Australia B Appl Science
Research Interests

Cancer Biology and Clinical Oncology Innovative Therapeutics

Language	Competency
Italian	Can read, write, speak and understand spoken

Date	Institution name	Country	Title
1996	Flinders University	Australia	Ph D
1986	University of South Australia	Australia	B Appl Science

Journals

Year	Citation
2023	Khan, S., Lokman, N. A., Oehler, M. K., Ricciardelli, C., & Yool, A. J. (2023). Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels.. Cancers, 15(18), 4507. DOI
2023	Arentz, G., Mittal, P., Klingler-Hoffmann, M., Condina, M. R., Ricciardelli, C., Lokman, N. A., . . . Hoffmann, P. (2023). Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer. Cancers, 15(7), 14 pages. DOI
2023	Bandara, V., Foeng, J., Gundsambuu, B., Norton, T. S., Napoli, S., McPeake, D. J., . . . Barry, S. C. (2023). Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7. Nature Communications, 14(1), 5546. DOI
2022	Khetan, R., Dharmayanti, C., Gillam, T. A., Kübler, E., Klingler-Hoffmann, M., Ricciardelli, C., . . . Albrecht, H. (2022). Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers, 14(10), 1-32. DOI Scopus3 WoS3 Europe PMC2
2022	Acland, M., Lokman, N. A., Young, C., Anderson, D., Condina, M., Desire, C., . . . Klingler-Hoffmann, M. (2022). Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations. Cancers, 14(11), 1-24. DOI Scopus3 WoS3 Europe PMC3
2022	Leung, D., Price, Z. K., Lokman, N. A., Wang, W., Goonetilleke, L., Kadife, E., . . . Ahmed, N. (2022). Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism. Journal of Translational Medicine, 20(1), 23 pages. DOI Scopus7 WoS7 Europe PMC4
2022	Price, Z. K., Lokman, N. A., Yoshihara, M., Kajiyama, H., Oehler, M. K., & Ricciardelli, C. (2022). Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways. International Journal of Molecular Sciences, 24(1), 696. DOI Scopus2 WoS2 Europe PMC2
2022	Khan, S., Varricchio, A., Ricciardelli, C., & Yool, A. J. (2022). Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant doses.. Frontiers in Oncology, 12, 15 pages. DOI Scopus1 WoS1 Europe PMC1
2021	Lee, E., Lokman, N. A., Oehler, M. K., Ricciardelli, C., & Grutzner, F. (2021). A comprehensive molecular and clinical analysis of the piRNA pathway genes in ovarian cancer. Cancers, 13(1), 1-23. DOI Scopus1 WoS1 Europe PMC1
2021	Cheung, J., Lokman, N. A., Abraham, R. D., Macpherson, A. M., Lee, E., Grutzner, F., . . . Ricciardelli, C. (2021). Reduced gonadotrophin receptor expression is associated with a more aggressive ovarian cancer phenotype. International Journal of Molecular Sciences, 22(1), 71-1-71-21. DOI Scopus9 WoS9 Europe PMC8
2021	Jankovic-Karasoulos, T., McAninch, D., Dixon, C., Leemaqz, S. Y. -L., François, M., Leifert, W. R., . . . Bianco-Miotto, T. (2021). The effect of zinc on human trophoblast proliferation and oxidative stress. The Journal of Nutritional Biochemistry, 90, 1-10. DOI WoS1 Europe PMC1
2021	Lokman, N. A., Ricciardelli, C., Stephens, A. N., Jobling, T. W., Hoffmann, P., & Oehler, M. K. (2021). Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer. Diagnostics, 11(1), 1-10. DOI Scopus4 WoS4 Europe PMC3
2021	Khan, S., Ricciardelli, C., & Yool, A. J. (2021). Targeting aquaporins in novel therapies for male and female breast and reproductive cancers. Cells, 10(2), 1-18. DOI Scopus13 WoS12 Europe PMC8
2021	Habibi, N., Labrinidis, A., Leemaqz, S. Y. -L., Jankovic-Karasoulos, T., McCullough, D., Grieger, J. A., . . . Bianco-Miotto, T. (2021). Effect of selenium and iodine on oxidative stress in the first trimester human placenta explants. Nutrients, 13(3), 1-14. DOI Scopus6 WoS5 Europe PMC2
2021	Wang, W., Lokman, N. A., Noye, T. M., Macpherson, A. M., Oehler, M. K., & Ricciardelli, C. (2021). ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome. Cancer Drug Resistance, 4(2), 485-502. DOI Scopus8 Europe PMC5
2021	Bantie, L., Tadesse, S., Likisa, J., Yu, M., Noll, B., Heinemann, G., . . . Wang, S. (2021). Erratum to “A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer” (Gynecologic Oncology (2020) 159(3) (827–838), (S0090825820339056), (10.1016/j.ygyno.2020.09.012)). Gynecologic Oncology, 163(1), 215. DOI
2021	Palasis, K. A., Lokman, N. A., Quirk, B. C., Adwal, A., Scolaro, L., Huang, W., . . . Abell, A. D. (2021). Optical fibre-enabled photoswitching for localised activation of an anti-cancer therapeutic drug. International Journal of Molecular Sciences, 22(19), 10844-1-10844-10. DOI Scopus3 WoS3 Europe PMC1
2020	Yoshihara, M., Kajiyama, H., Yokoi, A., Sugiyama, M., Koya, Y., Yamakita, Y., . . . Kikkawa, F. (2020). Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.. Int J Cancer, 146(8), 2268-2280. DOI Scopus36 WoS34 Europe PMC22
2020	Jankovic-Karasoulos, T., Bianco-Miotto, T., Butler, M. S., Butler, L. M., McNeil, C. M., O'Toole, S. A., . . . Ricciardelli, C. (2020). Elevated levels of tumor apolipoprotein D independently predict poor outcome in breast cancer patients. Histopathology, 76(7), 976-987. DOI Scopus12 WoS11 Europe PMC10
2020	Bantie, L., Tadesse, S., Likisa, J., Yu, M., Noll, B., Heinemann, G., . . . Wang, S. (2020). A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer.. Gynecol Oncol, 159(3), 827-838. DOI Scopus8 WoS10 Europe PMC7
2020	Macpherson, A. M., Barry, S. C., Ricciardelli, C., & Oehler, M. K. (2020). Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.. J Clin Med, 9(9), 1-57. DOI Scopus13 WoS10 Europe PMC10
2019	Lokman, N. A., Ho, R., Gunasegaran, K., Bonner, W. M., Oehler, M. K., & Ricciardelli, C. (2019). Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer. Journal of Experimental and Clinical Cancer Research, 38(1), 10-1-10-12. DOI Scopus24 WoS20 Europe PMC15
2019	Tan, I. A., Frewin, K., Ricciardelli, C., & Russell, D. L. (2019). ADAMTS1 promotes adhesion to extracellular matrix proteins and predicts prognosis in early stage breast cancer patients. Cellular Physiology and Biochemistry, 52(6), 1553-1568. DOI Scopus7 Europe PMC5
2019	Christensen, M. V., Høgdall, C., Jensen, S. G., Lokman, N., Ricciardelli, C., Christensen, I. J., . . . Høgdall, E. (2019). Annexin A2 and S100A10 as candidate prognostic markers in epithelial ovarian cancer. Anticancer Research, 39(5), 2475-2482. DOI Scopus10 WoS8 Europe PMC6
2019	Rahaman, M. H., Lam, F., Zhong, L., Teo, T., Adams, J., Yu, M., . . . Wang, S. (2019). Targeting CDK9 for treatment of colorectal cancer. Molecular Oncology, 13(10), 16 pages. DOI Scopus33 WoS30 Europe PMC16
2019	Lokman, N. A., Price, Z. K., Hawkins, E. K., Macpherson, A. M., Oehler, M. K., & Ricciardelli, C. (2019). 4-Methylumbelliferone inhibits cancer stem cell activation and overcomes chemoresistance in ovarian cancer. Cancers, 11(8), 1-18. DOI Scopus23 WoS22 Europe PMC17
2019	Mittal, P., Price, Z. K., Lokman, N. A., Ricciardelli, C., Oehler, M. K., Klingler-Hoffmann, M., & Hoffmann, P. (2019). Matrix Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI MSI) for monitoring of drug response in primary cancer spheroids. Proteomics, 19(21 - 22), e1900146-1-e1900146-4. DOI Scopus12 WoS10 Europe PMC9
2019	Zhang, A. Y., Chiam, K., Haupt, Y., Fox, S., Birch, S., Tilley, W., . . . Kench, J. G. (2019). An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy. International Journal of Cancer, 144(5), 1151-1159. DOI Scopus10 WoS10 Europe PMC4
2018	Price, Z., Lokman, N., & Ricciardelli, C. (2018). Differing roles of hyaluronan molecular weight on cancer cell behavior and chemotherapy resistance. Cancers, 10(12), 482-1-482-21. DOI Scopus48 WoS47 Europe PMC23
2018	Noye, T. M., Lokman, N. A., Oehler, M. K., & Ricciardelli, C. (2018). S100A10 and cancer hallmarks: Structure, functions, and its emerging role in Ovarian cancer. International Journal of Molecular Sciences, 19(12), 16 pages. DOI Scopus27 WoS27 Europe PMC18
2018	Ricciardelli, C., Lokman, N., Sabit, I., Gunasegaran, K., Bonner, W., Pyragius, C., . . . Oehler, M. (2018). Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics. Cancer Letters, 421, 51-58. DOI Scopus25 WoS24 Europe PMC17
2018	Ricciardelli, C., Bianco-Miotto, T., Jindal, S., Butler, L., Leung, S., McNeil, C., . . . Tilley, W. (2018). The magnitude of androgen receptor positivity in breast cancer is critical for reliable prediction of disease outcome. Clinical Cancer Research, 24(10), 2328-2341. DOI Scopus55 WoS51 Europe PMC39
2017	Ricciardelli, C., Lokman, N., Pyragius, C., Ween, M., Macpherson, A., Ruszkiewicz, A., . . . Oehler, M. (2017). Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance. Oncotarget, 8(11), 17819-17832. DOI Scopus33 WoS33 Europe PMC28
2017	Shakya, R., Tarulli, G., Sheng, L., Lokman, N., Ricciardelli, C., Pishas, K., . . . Callen, D. (2017). Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer. Oncogene, 36(31), 4469-4480. DOI Scopus31 WoS31 Europe PMC27
2016	Lokman, N. A., Pyragius, C. E., Ruszkiewicz, A., Oehler, M. K., & Ricciardelli, C. (2016). Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome. Translational Research, 171, 83-95.e2. DOI Scopus34 WoS30 Europe PMC25
2016	Ricciardelli, C. (2016). My pathway to understanding the role of the tumour microenvironment in cancer progression. Endocrine-Related Cancer, 23(11), P27-P31. DOI Scopus1 WoS1 Europe PMC1
2016	Ricciardelli, C., Lokman, N., Ween, M., & Oehler, M. (2016). Ovarian cancer-peritoneal cell interactions promote extracellular matrix processing. Endocrine-Related Cancer, 23(11), T155-T168. DOI Scopus21 WoS17 Europe PMC14
2015	Ricciardelli, C., Lokman, N., Cheruvu, S., Tan, I., Ween, M., Pyragius, C., . . . Oehler, M. (2015). Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation. Clinical & Experimental Metastasis, 32(5), 441-455. DOI Scopus46 WoS46 Europe PMC31
2015	Ween, M., Armstrong, M., Oehler, M., & Ricciardelli, C. (2015). The role of ABC transporters in ovarian cancer progression and chemoresistance. Critical Reviews in Oncology/Hematology, 96(2), 220-256. DOI Scopus126 WoS112 Europe PMC83
2015	Shawky, M., Ricciardelli, C., Lord, M., Whitelock, J., Ferro, V., Britt, K., & Thompson, E. (2015). Proteoglycans: potential agents in mammographic density and the associated breast cancer risk. Journal of Mammary Gland Biology and Neoplasia, 20(3-4), 121-131. DOI Scopus17 WoS18 Europe PMC9
2015	Highet, A., Khoda, S., Buckberry, S., Leemaqz, S., Bianco-Miotto, T., Harrington, E., . . . Roberts, C. (2015). Hypoxia induced HIF-1/HIF-2 activity alters trophoblast transcriptional regulation and promotes invasion. European Journal of Cell Biology, 94(12), 589-602. DOI Scopus52 WoS49 Europe PMC30
2015	Hu, F., Dzaye, O., Hahn, A., Yu, Y., Scavetta, R., Dittmar, G., . . . Kettenmann, H. (2015). Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling. Neuro-Oncology, 17(2), 200-210. DOI Scopus112 WoS106 Europe PMC74
2014	Chiam, K., Ricciardelli, C., & Bianco-Miotto, T. (2014). Epigenetic biomarkers in prostate cancer: current and future uses. Cancer Letters, 342(2), 248-256. DOI Scopus65 WoS57 Europe PMC44
2014	Lim, S., Ricciardelli, C., Oehler, M., De Arao Tan, I., Russell, D., & Grützner, F. (2014). Overexpression of piRNA pathway genes in epithelial ovarian cancer. PLoS One, 9(6), e99687-1-e99687-11. DOI Scopus47 WoS44 Europe PMC30
2013	Chiam, K., Ryan, N., Ricciardelli, C., Day, T., Buchanan, G., Ochnik, A., . . . Bianco-Miotto, T. (2013). Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers. Prostate, 73(2), 182-193. DOI Scopus14 WoS13 Europe PMC12
2013	Lim, S., Tsend-Ayush, E., Kortschak, R., Jacob, R., Ricciardelli, C., Oehler, M., & Grutzner, F. (2013). Conservation and expression of piRNA pathway genes in male and female adult gonad of amniotes. Biology of Reproduction, 89(6), 1-13. DOI Scopus25 WoS22 Europe PMC16
2013	Ricciardelli, C., Ween, M., Lokman, N., Tan, I., Pyragius, C., & Oehler, M. (2013). Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer. BMC Cancer, 13(476), 1-12. DOI Scopus56 WoS50 Europe PMC39
2013	Tan, I., Ricciardelli, C., & Russell, D. (2013). The metalloproteinase ADAMTS1: A comprehensive review of its role in tumorigenic and metastatic pathways. International Journal of Cancer, 133(10), 2263-2276. DOI Scopus57 WoS55 Europe PMC40
2013	Lokman, N., Elder, A., Ween, M., Pyragius, C., Hoffmann, P., Oehler, M., & Ricciardelli, C. (2013). Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget, 4(8), 1199-1211. DOI Scopus55 WoS49 Europe PMC37
2013	Butler, M., Yang, X., Ricciardelli, C., Liang, X., Norman, R., Tilley, W., & Hickey, T. (2013). Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome. Fertility and Sterility, 99(7), 2076-2083. DOI Scopus5 WoS4 Europe PMC4
2013	Butler, M., Ricciardelli, C., Tilley, W., & Hickey, T. (2013). Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression. Hormones and Cancer, 4(3), 154-164. DOI Scopus19 WoS16 Europe PMC16
2013	Pyragius, C., Fuller, M., Ricciardelli, C., & Oehler, M. (2013). Aberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer. International Journal of Molecular Sciences (Online), 14(4), 7742-7756. DOI Scopus32 WoS31 Europe PMC24
2012	Ween, M., Oehler, M., & Ricciardelli, C. (2012). Transforming growth factor-beta-induced protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer. International Journal of Molecular Sciences, 13(8), 10461-10477. DOI Scopus86 WoS76 Europe PMC63
2012	Lokman, N., Elder, A., Ricciardelli, C., & Oehler, M. (2012). Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. International Journal of Molecular Sciences, 13(8), 9959-9970. DOI Scopus262 WoS228 Europe PMC164
2011	Ricciardelli, C., Frewin, K., Tan, I., Williams, E., Opeskin, K., Pritchard, M., . . . Russell, D. (2011). The ADAMTS1 protease gene is required for mammary tumor growth and metastasis. American Journal of Pathology, 179(6), 3075-3085. DOI Scopus54 WoS48 Europe PMC46
2011	Ween, M., Oehler, M., & Ricciardelli, C. (2011). Role of versican, hyaluronan and CD44 in ovarian cancer metastasis. International Journal of Molecular Sciences (Online), 12(2), 1009-1029. DOI Scopus93 WoS99 Europe PMC78
2011	Lokman, N., Ween, M., Oehler, M., & Ricciardelli, C. (2011). The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenvironment, 4(2), 199-208. DOI Scopus185 Europe PMC140
2011	Ween, M., Hummitzsch, K., Rodgers, R., Oehler, M., & Ricciardelli, C. (2011). Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. Clinical & Experimental Metastasis, 28(2), 113-125. DOI Scopus55 WoS54 Europe PMC40
2011	Ween, M., Lokman, N., Hoffmann, P., Rodgers, R., Ricciardelli, C., & Oehler, M. (2011). Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. International Journal of Cancer, 128(7), 1-15. DOI Scopus57 WoS55 Europe PMC50
2011	Martin, K., Ricciardelli, C., Hoffmann, P., & Oehler, M. (2011). Exploring the immunoproteome for ovarian cancer biomarker discovery. International Journal of Molecular Sciences (Online), 12(1), 410-428. DOI Scopus7 WoS5 Europe PMC3
2011	Pawlak, P. L., Panda, M., Loloee, R., Kucera, B. E., Costes, J. -P., Tuchagues, J. -P., & Chavez, F. A. (2011). New binuclear Mn-II and Fe-II complexes supported by 1,4,8-triazacycloundecane. DALTON TRANSACTIONS, 40(12), 2926-2931. DOI WoS13 Europe PMC2
2010	Murti, K., Butler, L., Sakko, A., Ricciardelli, C., Mitto, T., Octnick, A., . . . Tilley, W. (2010). Androgen receptor levels during progression of prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Medical Journal of Indonesia, 19(1), 5-13. DOI Scopus2
2010	Bianco-Miotto, T., Chiam, K., Buchanan, G., Jindal, S., Day, T., Thomas, M., . . . Ricciardelli, C. (2010). Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. Cancer Epidemiology Biomarkers & Prevention, 19(10), 2611-2622. DOI Scopus132 WoS112 Europe PMC79
2010	Ricciardelli, C., Bianco-Miotto, T., Jindal, S., Dodd, T., Cohen, P., Marshall, V., . . . Horsfall, D. (2010). Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomies. Cancer Epidemiology Biomarkers & Prevention, 19(7), 1755-1765. DOI Scopus11 WoS11 Europe PMC7
2010	Callen, D., Ricciardelli, C., Butler, M., Stapleton, A., Stahl, J., Kench, J., . . . Holm, R. (2010). Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome. Oncology Reports, 23(4), 1045-1052. DOI Scopus10 WoS10 Europe PMC9
2010	Sigurdardottir, K. R., Haugen, D. F., van der Rijt, C. C. D., Sjogren, P., Harding, R., Higginson, I. J., & Kaasa, S. (2010). Clinical priorities, barriers and solutions in end-of-life cancer care research across Europe. Report from a workshop. EUROPEAN JOURNAL OF CANCER, 46(10), 1815-1822. DOI WoS35 Europe PMC23
2009	Peters, A., Buchanan, G., Ricciardelli, C., Bianco-Miotto, T., Centenera, M., Harris, J., . . . Tilley, W. (2009). Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Research, 69(15), 6131-6140. DOI Scopus309 WoS295 Europe PMC208
2009	Ricciardelli, C., Sakko, A., Stahl, J., Tilley, W., Marshall, V., & Horsfall, D. (2009). Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome. Prostate, 69(7), 761-769. DOI Scopus18 WoS17 Europe PMC9
2009	Ricciardelli, C., & Oehler, M. (2009). Diverse molecular pathways in ovarian cancer and their clinical significance. Maturitas, 62(3), 270-275. DOI Scopus40 WoS37 Europe PMC26
2009	Ricciardelli, C., Sakko, A., Ween, M., Russell, D., & Horsfall, D. (2009). The biological role and regulation of versican levels in cancer. Cancer and Metastasis Reviews, 28(1-2), 233-245. DOI Scopus185 WoS176 Europe PMC136
2008	Sakko, A., Butler, M., Byers, S., Reinboth, B., Stahl, C., Kench, J., . . . Ricciardelli, C. (2008). Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse. Cancer Epidemiology Biomarkers & Prevention, 17(9), 2488-2497. DOI Scopus25 WoS25 Europe PMC14
2008	Ricciardelli, C., Jackson, M., Choong, C., Stahl, J., Marshall, V., Horsfall, D., & Tilley, W. (2008). Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential. Prostate, 68(8), 830-838. DOI Scopus38 WoS36 Europe PMC32
2007	Buchanan, G., Ricciardelli, C., Harris, J., Prescott, J., Yu, Z., Jia, L., . . . Tilley, W. (2007). Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine-rich tetratricopeptide repeat containing protein α. Cancer Research, 67(20), 10087-10096. DOI Scopus79 WoS76 Europe PMC63
2007	Ricciardelli, C., Russell, D., Ween, M., Mayne, K., Suwiwat, S., Byers, S., . . . Horsfall, D. (2007). Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. Journal of Biological Chemistry, 282(14), 10814-10825. DOI Scopus125 WoS124 Europe PMC94
2007	Sakko, A., Ricciardelli, C., Mayne, K., Dours-Zimmermann, M., Zimmermann, D., Neufing, P., . . . Horsfall, D. (2007). Changes in steroid receptors and proteoglycan expression in the guinea pig prostate stroma during puberty and hormone manipulation. Prostate, 67(3), 288-300. DOI Scopus8 WoS9 Europe PMC6
2006	Ricciardelli, C., & Rodgers, R. (2006). Extracellular matrix of ovarian tumors. Seminars in Reproductive Medicine, 24(4), 270-282. DOI Scopus108 WoS95 Europe PMC68
2006	Butler, L., Centenera, M., Neufing, P., Buchanan, G., Choong, C., Ricciardelli, C., . . . Tilley, W. (2006). Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant. Molecular Endocrinology, 20(5), 1009-1024. DOI Scopus15 WoS14 Europe PMC10
2005	Buchanan, G., Birrell, S., Peters, A., Bianco-Miotto, T., Ramsay, K., Cops, E., . . . Tilley, W. (2005). Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate. Cancer Research, 65(18), 8487-8496. DOI Scopus60 WoS58 Europe PMC46
2004	Ricciardelli, C., Choong, C., Buchanan, G., Vivekanandan, S., Neufing, P., Stahl, J., . . . Tilley, W. (2004). Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease. Prostate, 63(1), 19-28. DOI Scopus101 WoS94 Europe PMC71
2004	Jia, L., Choong, C., Ricciardelli, C., Kim, J., Tilley, W., & Coetzee, G. (2004). Androgen receptor signaling: mechanism of interleukin-6 inhibition. Cancer Research, 64(7), 2619-2626. DOI Scopus75 WoS66 Europe PMC45
2004	Suwiwat, S., Ricciardelli, C., Tammi, R., Tammi, M., Auvinen, P., Kosma, V., . . . Horsfall, D. (2004). Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clinical Cancer Research, 10(7), 2491-2498. DOI Scopus127 WoS125 Europe PMC93
2004	Hall, R., Horsfall, D., Stahl, J., Vivekanandan, S., Ricciardelli, C., Stapleton, A., . . . Tilley, W. (2004). Apolipoprotein-D: A novel cellular marker for HGPIN and prostate cancer. Prostate, 58(2), 103-108. DOI Scopus28 WoS30 Europe PMC24
2003	Neufing, P., Kalionis, B., Horsfall, D., Ricciardelli, C., Stahl, J., Vivekanandan, S., . . . Tilley, W. (2003). Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues. Anticancer Research, 23(2B), 1479-1488. Scopus19 WoS19 Europe PMC16
2003	Sakko, A., Ricciardelli, C., Mayne, K., Suwiwat, S., LeBaron, R., Marshall, V., . . . Horsfall, D. (2003). Modulation of prostate cancer cell attachment to matrix by Versican. Cancer Research, 63(16), 4786-4791. Scopus73 WoS71 Europe PMC58
2002	Ricciardelli, C., Brooks, J., Suwiwat, S., Sakko, A., Mayne, K., Raymond, W., . . . Horsfall, D. (2002). Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clinical Cancer Research, 8(4), 1054-1060. Scopus132 WoS134 Europe PMC96
2002	Jackson, M., Roberts, J., Heckford, S., Ricciardelli, C., Stahl, J., Horsfall, D., & Tilley, W. (2002). A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Research, 62(3), 854-859. Scopus171 WoS158 Europe PMC100
2001	Sakko, A., Ricciardelli, C., Mayne, K., Tilley, W., LeBaron, R., & Horsfall, D. (2001). Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Cancer Research, 61(3), 926-930. Scopus91 WoS89 Europe PMC64
1999	Lockwood, C., Ricciardelli, C., Raymond, W., Seshadri, R., McCaul, K., & Horsfall, D. (1999). A simple index using video image analysis to predict disease outcome in primary breast cancer. International Journal of Cancer, 84(3), 203-208. DOI Scopus26 WoS23 Europe PMC16
1999	Ricciardelli, C., Quinn, D., Raymond, W., McCaul, K., Sutherland, P., Stricker, P., . . . Horsfall, D. (1999). Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer. Cancer Research, 59(10), 2324-2328. Scopus53 WoS52 Europe PMC35
1998	Ricciardelli, C., Mayne, K., Sykes, P. J., Raymond, W. A., McCaul, K., Marshall, V. R., & Horsfall, D. J. (1998). Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clinical Cancer Research, 4(4), 963-971. Scopus158 WoS158 Europe PMC115
1998	Zhang, S., Bentel, J., Ricciardelli, C., Horsfall, D., Haagensen, D., Marshall, V., & Tilley, W. (1998). Immunolocalization of apolipoprotein d, androgen receptor and prostate specific antigen in early stage prostate cancers. Journal of Urology, 159(2), 548-554. DOI Scopus21 WoS21 Europe PMC16
1997	Ricciardelli, C., Mayne, K., Sykes, P. J., Raymond, W. A., McCaul, K., Marshall, V. R., . . . Horsfall, D. J. (1997). Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. Clinical Cancer Research, 3(6), 983-992. Scopus81 WoS80 Europe PMC53
1995	Birrell, S., Bentel, J., Hickey, T., Ricciardelli, C., Weger, M., Horsfall, D., & Tilley, W. (1995). Androgens induce divergent proliferative responses in human breast cancer cell lines. Journal of Steroid Biochemistry and Molecular Biology, 52(5), 459-467. DOI Scopus225 WoS247 Europe PMC158
1994	Horsfall, D. J., Mayne, K., Ricciardelli, C., Mohan, R., Skinner, J. M., Henderson, D. W., . . . Tilley, W. D. (1994). Age-related changes in guinea pig prostatic stroma. Laboratory Investigation, 70(5), 753-763. DOI Scopus53 WoS46 Europe PMC36
1994	Ricciardelli, C., Horsfall, D. J., Sykes, P. J., Marshall, V. R., & Tilley, W. D. (1994). Effects of oestradiol 17-β and 5α-dihydrotestosterone on guinea-pig prostate smooth muscle cell proliferation and steroid receptor expression. Journal of Endocrinology, 140(3), 373-383. DOI Scopus21 WoS19 Europe PMC11
1989	Horsfall, D., Goldsmith, K., Ricciardelli, C., Skinner, J., Tilley, W., & Marshall, V. (1989). Steroid hormone and epidermal growth factor receptors in meningiomas. Australian and New Zealand Journal of Surgery, 59(11), 881-888. DOI Scopus16 WoS16 Europe PMC12
1989	Ricciardelli, C., Horsfall, D., Skinner, J., Henderson, D., Marshall, V., & Tilley, W. (1989). Development and characterization of primary cultures of smooth muscle cells from the fibromuscular stroma of the guinea pig prostate. In Vitro Cellular & Developmental Biology, 25(11), 1016-1024. DOI Scopus29 WoS32 Europe PMC23

Book Chapters

Year	Citation
2020	Lokman, N. A., Ricciardelli, C., & Oehler, M. K. (2020). Chick chorioallantoic membrane assay: a 3D animal model for cancer invasion and metastasis. In A. S. VERMA, & A. SINGH (Eds.), Animal Biotechnology Models in Discovery and Translation (2nd ed., pp. 221-231). London, United Kingdom: Academic Press. DOI Scopus3
2009	Ricciardelli, C., Sakko, A., Ween, M., Russell, D., & Horsfall, D. (2009). The proteoglycan versican: an important regulator of cell locomotion in development and disease. In T. Abreu, & G. Silva (Eds.), Cell movement : new research trends (pp. 1-19). Nova Science Publishers.

Conference Papers

Year	Citation
2023	Thompson, E. J., Bandara, V., Gundsambuu, B., Napoli, S., Mills, S., Foeng, J., . . . Bonder, C. S. (2023). Assessing LGR5 expression levels on colorectal cancer tissue samples for use in LGR5-targeting CAR-T cell therapy clinical trial. In CANCER RESEARCH Vol. 83 (pp. 2 pages). Orlando, FL: AMER ASSOC CANCER RESEARCH. DOI
2019	Lokman, N., Ho, R., Gunasegaran, K., Bonner, W., Oehler, M., & Ricciardelli, C. (2019). All trans retinoic acid promotes apoptosis and inhibits serous ovarian cancer invasion. In CLINICAL & EXPERIMENTAL METASTASIS Vol. 36 (pp. 152). SPRINGER.
2011	Ricciardelli, C., Lokman, N. A., Ween, M. P., Hoffman, P., & Oehler, M. K. (2011). Role of annexin A2 in ovarian cancer metastasis. In CLINICAL & EXPERIMENTAL METASTASIS Vol. 28 (pp. 215). SPRINGER.
2011	Patterson, K., Sakko, A., Ricciardelli, C., Proudman, S., & Hissaria, P. (2011). EVALUATION OF ANGIOGENIC AND FIBROGENIC CYTOKINES AS BIOMARKERS IN SUBGROUPS OF SYSTEMIC SCLEROSIS. In INTERNAL MEDICINE JOURNAL Vol. 41 (pp. 9-10). WILEY-BLACKWELL.
2009	Ricciardelli, C., Frewin, K., Ingman, W., & Russell, D. L. (2009). Role of Adamts1 in mammary cancer growth and metastasis. In CLINICAL & EXPERIMENTAL METASTASIS Vol. 26 (pp. 922). SPRINGER.
2006	Murphy, N., Bianco-Miotto, T., Ricciardelli, C., Ruiz, A., Segara, D., McNeil, C., . . . Tilley, W. (2006). Expression of the androgen receptor and its association with disease outcome in breast cancer. In Breast Cancer Research and Treatment Vol. 100 (pp. S262-S263). San Antonio, Texas: Springer.

Conference Items

Year	Citation
2021	Khan, S., Ricciardelli, C., & Yool, A. (2021). EPV114/# 325 Expression of aquaporins in human endometrial cancer: identification and regulation by ovarian hormones in carcinogenesis of endometrial cancer. Poster session presented at the meeting of International gynaecological cancer society.
2021	Khan, S., Ricciardelli, C., & Yool, A. (2021). Fuling inhibits invasion in endometrial cancer cells.. Poster session presented at the meeting of EMBL Australia.
2021	Khan, S., Ricciardelli, C., & Yool, A. (2021). Fuling inhibits invasion in endometrial cancer cells. Poster session presented at the meeting of Australian Metastasis Research Society (OzMRS).
2021	Khan, S., Ricciardelli, C., & Yool, A. (2021). Fuling inhibits invasion in endometrial cancer cells. Poster session presented at the meeting of Australian Physiological society (AuPS) (oral presentation).
2021	Khan, S., Ricciardelli, C., & Yool, A. (2021). Identification of Aquaporins in human endometrial cancer and regulation by ovarian hormones in carcinogenesis.. Poster session presented at the meeting of The Australian Society for Medical Research National Scientific Conference, Adelaide, Australia..
2019	Lokman, N. A., Ho, R., Gunasegaran, K., Bonner, W. M., Oehler, M. K., & Ricciardelli, C. (2019). ANTI-TUMOUR EFFECTS OF ALL-TRANS RETINOID ACID, AN ANNEXIN A2-S100A10 PATHWAY INHIBITOR ON SEROUS OVARIAN CANCER. Poster session presented at the meeting of CLINICAL CANCER RESEARCH. Seattle, WA: AMER ASSOC CANCER RESEARCH.
2018	Zhang, A., Chiam, K., Haupt, Y., Fox, S., Birch, S., Tilley, W., . . . Kench, J. (2018). An analysis of multiple biomarkers to better predict prostate cancer metastasis after radical prostatectomy. Poster session presented at the meeting of Asia-Pacific Journal of Clinical Oncology. Adelaide: Wiley.
2015	Lokman, N. A., Elder, A. S. F., Ween, M. P., Pyragius, C. E., Hoffmann, P., Ruszkiewicz, A., . . . Ricciardelli, C. (2015). Annexin A2 a potential prognostic marker for serous ovarian cancer promotes ovarian cancer metastasis. Poster session presented at the meeting of CLINICAL & EXPERIMENTAL METASTASIS. SPRINGER. WoS1
2015	Ricciardelli, C., Cheruvu, S., Lokman, N. A., Ween, M. P., Tan, I. A., Pyragius, C. E., . . . Oehler, M. K. (2015). Transketolase a protein regulated by ovarian cancer-peritoneal interactions is elevated in omental metastases and regulates serous ovarian cancer proliferation. Poster session presented at the meeting of CLINICAL & EXPERIMENTAL METASTASIS. SPRINGER.
2014	Lokman, N. A., Elder, A. S. F., Ween, M. P., Pyragius, C. E., Hoffmann, P., Ruszkiewicz, A., . . . Oehler, M. K. (2014). ANNEXIN A2 A POTENTIAL PROGNOSTIC MARKER FOR SEROUS OVARIAN CANCER PROMOTES OVARIAN CANCER METATASIS. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. LIPPINCOTT WILLIAMS & WILKINS.
2008	Hickey, T., Butler, M., Ricciardelli, C., Norman, R., & Tilley, W. (2008). Expression of small glutamine-rich tetratricopeptide repeat-containing protein alpha (alpha SGT), a novel regulator of androgen receptor (AR) activity, in the human ovary and fallopian tube. Poster session presented at the meeting of Biology of Reproduction. Kailua-Kona, Hawaii: Oxford University Press. DOI WoS1
2006	Buchanan, G., Ricciardelli, C., Prescott, J., Harris, J. M., Yu, Z. C. -L., Jia, L., . . . Tilley, W. D. (2006). αSGT: A critical determinant of androgen receptor function in prostate cancer. Poster session presented at the meeting of Cancer Research. Washington, DC: American Association for Cancer Research.

Date	Project/ No.	Investigators	Funding Body	Amount
2011	Extracellular matrix-macrophage cross talk in the mammary gland	Ingman WV, Ricciardelli C, Sharkey D, Russell DL	Robinson Institute (Collaborative Funding scheme)	$12,000
2011	Infrared fluorescence imager for protein quantitation and cultured cell or whole animal imaging	Russell DL, Robertson S, Thompson J, Rodgers RJ, Roberts C, Norman R, Gilchrist R, Kennaway D, Ingman WV, M ottershead D, Lane M, Robker RL, Ricciardelli C, Oehler MK	NHMRC equipment grant	$35000
2011-2012	Control of breast cancer density and cancer risk by epithelial-stromal interactions	WV Ingman, M Pike, *Ricciardelli C ,** Russell DL , Sharkey D , Tilley WD, Wu A	National Breast Cancer Foundation (Novel concept award)	$199,772
2012	Hyaluronan: a marker of ovarian cancer chemoresistance	Ricciardelli C, Oehler MK	RAH Clinical Research Fund	$23,000
2012	High throughput image analysis system for histoquantification of histology images	Ricciardelli C, Owens J, Wittert G, Roberts CT, Tilley WD, Callen D, Russell DL, Ingman WV, Rodgers RJ, Keefe D, Findlay D	NHMRC equipment grant (GNT 1038556) Faculty of Health Sciences Robinson Institute	$60,000 $15,000 $20,200
2012	Annexin A2: a novel biomarker and therapeutic target for ovarian cancer	Ricciardelli C, Oehler MK, Rodgers RJ	Cancer Council SA/SAHMRI	$93,723
2012-2013	Targeting the cancer peritoneal interaction	Ricciardelli C, Oehler MK, Hoffmann P	SAHMRI/OCRF	$50,000
2013	Hyaluronan: a marker and therapeutic target to overcome ovarian cancer chemoresistance	Ricciardelli C, Oehler MK, Heinzelmann-Schwarz V, Stephens A *	Cancer Council SA/SAHMRI	$93,891
2013-2014	Targeting the interaction between breast cancer and Toll-like receptors of the immune system to prevent metastasis	Russell DL, Ricciardelli C, Hutchinson M	SAHMRI	$40,000
2013	Targeting the annexin A2 signalling pathway to block ovarian cancer metastasis	Ricciardelli C, Oehler MK	Robinson Institute	$13,700
2014	The annexin A2 signalling pathway: Novel biomarkers and therapeutic targets for serous ovarian cancer	Ricciardelli C, Oehler MK, Rodgers RJ	Robinson Research Institute	$22,700
2015		Ricciardelli C	Lloyd Cox Fellowship, School of Paediatrics and Reproductive Health	$132,367
2015	Annexin A2 as a novel diagnostic marker for ovarian cancer	Ricciardelli C, Oehler MK	Commercial Accelerator Scheme Development grant, Adelaide Research Innovation	$25,000
2016-2020	Tumour-host signalling pathways: Identification of novel ovarian cancer biomarkers and therapeutic targets	Ricciardelli C	Lin Huddleston Ovarian Cancer Fellowship, Cancer Council SA & School of Medicine, University of Adelaide	$750,000
2018-2020	Evaluating CAR-T cells on ovarian cancer using ex vivo and in vivo models	Oehler MK Ricciardelli C	CTM@CRC Limited and Carina Biotech	$136,000

Dr. Ricciardelli has been actively teaching undergraduates in the 3rd Year unit Human reproduction III of the Bachelor of Health Science degree (lecturing and workshops) since 2007.

Problem based learning (PBL) tutor in School of Medicine, Flinders University of SA, Endocrinology, 1999
Human Reproduction III course, University of Adelaide Lecture “Cancer: Incidence, Development and Treatment” 2007-present
Human Reproduction III course, University of Adelaide Workshop “Fertility preservation in patients diagnosed with cancer” 2007-present

Current Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2021	Principal Supervisor	Mechanism of Metastasis in Ovarian Cancer	Doctor of Philosophy under a Jointly-awarded Degree Agreement with	Doctorate	Full Time	Mr Hiroki Fujimoto
2020	Principal Supervisor	Development of novel ovarian cancer treatment using CAR-T cells targeting LGR5	Doctor of Philosophy	Doctorate	Full Time	Miss Wanqi Wang
2020	Co-Supervisor	Analysing the role of Aquaporin channels in the progression of endometrial carcinoma	Doctor of Philosophy	Doctorate	Part Time	Ms Sidra Nawaz Khan
2018	Principal Supervisor	Role of Hyaluronan in Ovarian Cancer Signalling Pathways and Chemoresistance	Doctor of Philosophy under a Jointly-awarded Degree Agreement with	Doctorate	Full Time	Miss Zoe Kathleen Price

Past Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2017 - 2021	Co-Supervisor	The Role of piRNA Pathway Genes in Ovarian and Prostate Cancer Progression	Doctor of Philosophy	Doctorate	Full Time	Miss Eunice Hsiu Yee Lee
2016 - 2020	Principal Supervisor	Clinical and Basic Research for Ovarian Cancer	Doctor of Philosophy under a Jointly-awarded Degree Agreement with	Doctorate	Full Time	Mr Masato Yoshihara
2011 - 2014	Principal Supervisor	Role of Annexin A2 in Ovarian Cancer Metastasis	Doctor of Philosophy	Doctorate	Full Time	Dr Noor Alia Lokman
2010 - 2016	Co-Supervisor	The Role of Estrogen Receptor and the Androgen Receptor in Human Breast Cancer	Doctor of Philosophy	Doctorate	Part Time	Mrs Shalini Jindal
2010 - 2015	Co-Supervisor	Utilising Quantitative Immunoproteomics To Reveal Differential Autoantibody Biomarker Panels In Serous Ovarian Cancer Patients	Doctor of Philosophy	Doctorate	Full Time	Mrs Karina Martin
2009 - 2014	Co-Supervisor	Adamts1 is a promoter of metastatic cell behaviour in mammary cancer cells	Doctor of Philosophy	Doctorate	Full Time	Miss Izza Maria Doreen De Arao Tan
2009 - 2010	Principal Supervisor	The Biological Role of Extracellular Matrix in Ovarian Cancer Metastasis	Doctor of Philosophy	Doctorate	Full Time	Miss Miranda Ween
2009 - 2012	Co-Supervisor	The Role of Small Glutamine-Rich Tetratricopeptide Repeat Containing Protein Alpha in Female Reproductive Tissues	Doctor of Philosophy	Doctorate	Full Time	Ms Miriam Simone Butler
2007 - 2010	Co-Supervisor	The Role of Epigenetic Modifications in Prostate Tumourigenesis	Doctor of Philosophy	Doctorate	Full Time	Ms Karen Huiqin Chiam
2004 - 2009	Co-Supervisor	Functional Analysis of CBFA2T3: A Breast Cancer Tumour Suppressor from Chromosome Band 16q24.3	Doctor of Philosophy	Doctorate	Full Time	Dr Zarqa Saif
2002 - 2004	Co-Supervisor	Versican: regulation, purification, and biological properties of a candidate prognostic indicator for breast cancer	Doctor of Philosophy	Doctorate	Full Time	Miss Supaporn Suwiwat

Position: Senior Research Fellow (C)
Phone: 83138255
Email: carmela.ricciardelli@adelaide.edu.au
Campus: North Terrace
Building: Adelaide Health and Medical Sciences, floor 5
Org Unit: Women's and Children's Health

Dr Carmela Ricciardelli

Appointments

Awards and Achievements

Language Competencies

Education

Research Interests